British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.

From 1979-1983, 299 patients with stage III or IV Hodgkin's disease (HD) were randomised to receive cyclical chemotherapy with MOPP (mustine, Oncovin, procarbazine, prednisone) or LOPP (Leukeran substituted for mustine). Two hundred and ninety patients were evaluable. There was no statistically...

Descripción completa

Detalles Bibliográficos
Autores principales: Hancock, B. W., Vaughan Hudson, G., Vaughan Hudson, B., Haybittle, J. L., Bennett, M. H., MacLennan, K. A., Jelliffe, A. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972355/
https://www.ncbi.nlm.nih.gov/pubmed/2021542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972355/
https://www.ncbi.nlm.nih.gov/pubmed/2021542

Ejemplares similares